Proteon Therapeutics LLC, a Kansas City biotech startup attempting to bring a new drug to market, has attracted an additional $1.2 million from individual investors, pushing its angel financing total to more than $2.7 million.
Proteon Therapeutics LLC, a Kansas City biotech startup attempting to bring a new drug to market, has attracted an additional $1.2 million from individual investors, pushing its angel financing total to more than $2.7 million.
